Keay Nakae

Stock Analyst at Chardan Capital

(4.20)
# 462
Out of 5,026 analysts
252
Total ratings
42.91%
Success rate
18.85%
Average return

Stocks Rated by Keay Nakae

Monopar Therapeutics
Sep 25, 2025
Maintains: Buy
Price Target: $60$85
Current: $82.56
Upside: +2.96%
SAB Biotherapeutics
Sep 19, 2025
Maintains: Buy
Price Target: $12
Current: $2.17
Upside: +453.00%
Coya Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $14
Current: $6.30
Upside: +122.22%
Avidity Biosciences
Sep 10, 2025
Maintains: Buy
Price Target: $75
Current: $48.78
Upside: +53.75%
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $3.68
Upside: +443.48%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $48.60
Upside: -48.56%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $38.97
Upside: +53.96%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $4.51
Upside: +10.86%
ProQR Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.80
Upside: +42.86%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $6.59
Upside: +431.11%
Maintains: Buy
Price Target: $325$400
Current: $481.07
Upside: -16.85%
Maintains: Buy
Price Target: $50$38
Current: $16.42
Upside: +131.43%
Maintains: Buy
Price Target: $5
Current: $0.85
Upside: +491.37%
Downgrades: Neutral
Price Target: $1.25$6
Current: $19.26
Upside: -68.85%
Maintains: Buy
Price Target: $20
Current: $3.73
Upside: +436.19%
Maintains: Buy
Price Target: $6
Current: $1.81
Upside: +231.49%
Maintains: Neutral
Price Target: $2.5
Current: $2.03
Upside: +23.15%
Maintains: Buy
Price Target: $10$8
Current: $0.75
Upside: +973.25%
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Maintains: Sell
Price Target: $8$6
Current: $18.09
Upside: -66.83%
Maintains: Buy
Price Target: $60$20
Current: $0.59
Upside: +3,285.81%
Maintains: Buy
Price Target: $65$55
Current: $9.40
Upside: +485.11%
Maintains: Neutral
Price Target: $1.25$10
Current: $4.90
Upside: +104.08%
Upgrades: Neutral
Price Target: $100$88
Current: $11.96
Upside: +631.61%
Downgrades: Neutral
Price Target: $0.7$13
Current: $1.61
Upside: +707.45%